Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2026-05-27
Product name:
ELMARO
DIN:
02568527
Product Monograph/Veterinary Labelling:
Date:
2026-03-30
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ELANCO CANADA LIMITED
150 Research Lane Suite 120
Guelph
Ontario
Canada
N1G 4T2
Class:
Veterinary
Species:
Cats , Dogs
Dosage form(s):
Solution
Route(s) of administration:
Intravenous , Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
PRESCRIPTION
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0152295005
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| MAROPITANT (MAROPITANT CITRATE) | 10 MG / ML |